ArticleLancet (London, England)2020
Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Targeting natural products against SARS-CoV-2.Environmental science and pollution research international · 2022Review
- Article
- The protective role of vitamin C in the management of COVID-19: A Review.The Journal of the Egyptian Public Health Association · 2021Review
- Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter.Postgraduate medical journal · 2021Article
- COVID-19 and the generation of novel scientific knowledge: Research questions and study designs.Journal of evaluation in clinical practice · 2021Article
- Clinical Research Redirection and Optimization During a Pandemic.Anesthesiology clinics · 2021Review
- Optimizing peer review to minimize the risk of retracting COVID-19-related literature.Medicine, health care, and philosophy · 2021Article
- Progress in the risk assessment of hydroxychloroquine in frail elderly people.Aging medicine (Milton (N.S.W)) · 2021Review
- Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.Frontiers in immunology · 2021Article
- Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review.Journal of medical virology · 2021Review
- Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.Journal of epidemiology · 2020Article
- Bibliometric evaluation of Latin American contributions on COVID-19Biomedica : revista del Instituto Nacional de Salud · 2020Article
- From quarantine room: Physician perspective.Journal of family medicine and primary care · 2020Article
- Review
- COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.European journal of medicinal chemistry · 2020Review
- Pathophysiology and treatment strategies for COVID-19.Journal of translational medicine · 2020Review
- A critical analysis and review of Lancet COVID-19 hydroxychloroquine study.Journal of market access & health policy · 2020Review
- Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence.Infection & chemotherapy · 2020Review
- Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19.Lancet (London, England) · 2020Article
- BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?Cell death & disease · 2020Article
Corrections and comments
- Retraction · 2020-07-09Cites Retracted Work · Retract and Replace ·
- Retracted
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.